Emrullah Yilmaz, MD, PhD, clinical assistant professor, Hematology and Medical Oncology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; member, Immune Oncology Program, Case Comprehensive Cancer Center, discusses a study investigating HB-200 arenavirus–based immunot...
Suneel Kamath, MD, assistant professor, medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, discusses tumor microbiome differences in early-onset vs average-onset pancreatic ductal adenocarcinoma (PDAC). Notably, at the 2024 ASCO Annual Meeting, investigators presente...
awadhi reply to waller et al. standardizing surgical treatment for mesothelioma. joseph s. friedberg, melissa culligan, anne s. tsao, valerie w. rusch, prasad s. adusumilli, boris sepesi, harvey i. pass, raphael bueno, bryan m. burt, david j. sugarbaker, marc de perrot, alex a. ...
Hofstra Clinic Holocaust Museum Homicide Homophobia Homophobia Hon. Hon. Amiena Khan Hon. Andrew Arthur Hon. Bruce Einhorn Hon. Charles E. Pazar Hon. Charles Honeyman Hon. Constance Baker Motley (1921-2005) Hon. Cynthia S. Torg Hon. David Hon. David Estudillo Hon. Eliza...
Ruben Olivares, MD, urologic surgeon, associate professor, Urology, Glickman Urological Institute, Cleveland Clinic, discusses the functional advantages of using focal therapy over localized radiation in prostate cancer, as well as the use of failure-free survival (FFS) as a surrogate end point...
Centre for Clinical Research and Effective Practice (CCREP) Middlemore Hospital Baker, John, R 新西兰 Auckland Auckland Auckland City Hospital Benatar, Jocelyne, R 新西兰 Auckland Auckland Clinical Horizons NZ Ltd Corin, Andrew, P 新西兰 Tauranga Tauranga Rotorua Hospital DeCaigney, Susan, C 新西兰 ...
G. Thomas Budd, MD, Medical Oncologist, Taussig Cancer Center at Cleveland Clinic, Professor, Hematology & Medical Oncology, Case Western Reserve University, discusses prior treatment with trastuzumab and the effect on two regimens of paclitaxel....
Dr Baker on the EMBRACE Trial of the Dxcover Liquid Biopsy in Brain Cancer Dr Ahluwalia on the SURVIVE Trial of SurVaxM Plus Chemoradiation in Newly-Diagnosed Glioblastoma Dr Mascarenhas on Prior Data Showing the Efficacy of Navtemadlin in R/R Myelofibrosis...
Akriti Jain, MD, Department of Hematology and Medical Oncology, Cleveland Clinic, discusses the phase 1b VERONA study (NCT02942290) of venetoclax (Venclexta) with azacitidine (Vidaza) to assess change in complete remission (CR) and overall survival (OS) in patients with treatment-naive higher-...